Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Molecules (Basel, Switzerland)
|
October 23, 2021
Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3
Tehila Mizrachi, Adi Vaknin-Dembinsky, Talma Brenner, et al.
Cellular Immunology
|
January 21, 2020
Role of tissue plasminogen activator in clinical aggravation of experimental autoimmune encephalomyelitis and its therapeutic potential
Tehila Mizrachi, Devorah Gur-Wahnon, Abd Al-Roof Higazi, et al.
Central Nervous System Agents in Medicinal Chemistry
|
August 31, 2016
Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway
Millet Treinin, Roger L Papke, Eran Nizri, et al.
Journal of Autoimmunity
|
January 16, 2014
Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential
Devorah Gur-Wahnon, Tehila Mizrachi, Shane Wald-Altman, et al.
Molecular Brain
|
May 1, 2016
RIC-3 expression and splicing regulate nAChR functional expression
Yael Ben-David, Tehila Mizrachi, Sarah Kagan, et al.
Journal of Neuroinflammation
|
March 19, 2013
Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL
Hodaya Prinz-Hadad, Tehila Mizrachi, Michal Irony-Tur-Sinai, et al.
Journal of Neuroinflammation
|
October 15, 2013
The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention
Devorah Gur-Wahnon, Tehila Mizrachi, Florence-Yehudith Maaravi-Pinto, et al.
Journal of Neuroinflammation
|
April 27, 2021
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
Tehila Mizrachi, Oshrit Marsha, Karen Brusin, et al.
Journal of Immunology Research
|
June 29, 2018
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness
Tehila Mizrachi, Livnat Brill, Malcolm Rabie, et al.
Pharmacological Research
|
August 12, 2019
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine
Paola Cavalcante, Tehila Mizrachi, Claudia Barzago, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Molecules (Basel, Switzerland)
|
October 23, 2021
Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3
Tehila Mizrachi, Adi Vaknin-Dembinsky, Talma Brenner, et al.
Cellular Immunology
|
January 21, 2020
Role of tissue plasminogen activator in clinical aggravation of experimental autoimmune encephalomyelitis and its therapeutic potential
Tehila Mizrachi, Devorah Gur-Wahnon, Abd Al-Roof Higazi, et al.
Central Nervous System Agents in Medicinal Chemistry
|
August 31, 2016
Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway
Millet Treinin, Roger L Papke, Eran Nizri, et al.
Journal of Autoimmunity
|
January 16, 2014
Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential
Devorah Gur-Wahnon, Tehila Mizrachi, Shane Wald-Altman, et al.
Molecular Brain
|
May 1, 2016
RIC-3 expression and splicing regulate nAChR functional expression
Yael Ben-David, Tehila Mizrachi, Sarah Kagan, et al.
Journal of Neuroinflammation
|
March 19, 2013
Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL
Hodaya Prinz-Hadad, Tehila Mizrachi, Michal Irony-Tur-Sinai, et al.
Journal of Neuroinflammation
|
October 15, 2013
The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention
Devorah Gur-Wahnon, Tehila Mizrachi, Florence-Yehudith Maaravi-Pinto, et al.
Journal of Neuroinflammation
|
April 27, 2021
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
Tehila Mizrachi, Oshrit Marsha, Karen Brusin, et al.
Journal of Immunology Research
|
June 29, 2018
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness
Tehila Mizrachi, Livnat Brill, Malcolm Rabie, et al.
Pharmacological Research
|
August 12, 2019
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine
Paola Cavalcante, Tehila Mizrachi, Claudia Barzago, et al.
Page
of 2